search
Back to results

Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity

Primary Purpose

Morbid Obesity

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Gastric bypass surgery
Lap-Band
Sponsored by
University of California, Irvine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Morbid Obesity focused on measuring Morbid Obesity, Laparoscopic Gastric Bypass, Laparoscopic Gastric Banding

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Eligibility: Inclusion Criteria: Male or female patients with BMI of 40-60 kg/m2 or 35 kg/m2 with comorbidities Good health status with acceptable operative risk (good cardiopulmonary function) Willingness to follow protocol requirements: Signing informed consent, follow-up, and completing protocol diagnostic tests Exclusion Criteria: Prior upper abdominal surgery except cholecystectomy Large abdominal ventral hernia Patients with hiatal hernia Inadequate prior medical management Lack of patient's motivation and contribution to long-term success Unacceptable operative risk Minors and pregnant women are excluded as these patients do not qualify for the bariatric procedures. Minors are not psychologically fit to undergo such surgery and pregnant women are excluded because of safety for the fetus.

Sites / Locations

  • Univeristy of California, Irvine, Medical Center

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Laparoscopic Gastric Bypass

LAP-BAND

Arm Description

Subject undergoes Laparoscopic Gastric Bypass

Subject undergoes LAP-BAND procedure

Outcomes

Primary Outcome Measures

Excess Weight Loss From Pre-operation to 5 Years Post-operation
weight loss as measured by change in percent of excess body weight

Secondary Outcome Measures

Changes in Quality of Life- Physical Functioning Using SF-36 Questionnaire Pre-operation to 12 Months Post-operation
change in quality of life survey response where 0 is non-functioning and 100 is fully functioning
Cost of Procedure to the Medical Facility on Date of Procedure
operative and post-operative direct costs including hospital service costs per patient. costs reflect the average cost per patient in each of the two groups (band vs. bypass) at a single time point: date of surgery.
Changes in Quality of Life- Role- Physical Using SF-36 Questionnaire Pre-operation to 12 Months Post-operation
change in quality of life survey response for physical aspects of life using the SF-36 questionnaire where 0 corresponds to no Role-Physical and 100 corresponds to full Role-Physical
Changes in Quality of Life- Bodily Pain Using SF-36 Questionnaire Pre-operation to 12 Months Post-operation
change in quality of life survey response for bodily pain using the SF-36 questionnaire where 0 corresponds to no bodily pain and 100 corresponds to complete bodily pain
Changes in Quality of Life: General Health Using SF-36 Questionnaire Pre-operation to 12 Months Post-operation
change in quality of life survey response for general health using the SF-36 questionnaire where 0 corresponds to no general health satisfaction and 100 corresponds to complete health satisfaction
Changes in Quality of Life- Vitality Using SF-36 Questionnaire Pre-operation to 12 Months Post-operation
change in quality of life survey response for vitality as measured using the SF-36 questionnaire with worst score being 0 and best score being 100 on a 1-100 point scale.
Changes in Quality of Life- Social Functioning Using SF-36 Questionnaire Pre-operation to 12 Months Post-operation
change in quality of life survey response for social functioning as measured using the SF-36 questionnaire where 0 corresponds to no social functioning and 100 corresponds to full social functioning
Changes in Quality of Life- Role- Emotional Using SF-36 Questionnaire Pre-operation to 12 Months Post-operation
change in quality of life survey response for the emotional role using the SF-36 questionnaire where 0 corresponds to no emotional role and 100 corresponds to full emotional role
Changes in Quality of Life- Mental Health Using SF-36 Questionnaire From Pre-operation to 12 Months Post-operation
change in quality of life survey response for mental health using the SF-36 questionnaire where 0 corresponds to no mental health well-being and 100 corresponds to complete mental health well-being

Full Information

First Posted
October 31, 2005
Last Updated
March 28, 2023
Sponsor
University of California, Irvine
search

1. Study Identification

Unique Protocol Identification Number
NCT00247377
Brief Title
Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity
Official Title
A Prospective Randomized Trial of Laparoscopic Gastric Bypass vs Laparoscopic Adjustable Gastric Banding (LAP-BAND) for Treatment of Morbid Obesity
Study Type
Interventional

2. Study Status

Record Verification Date
March 2023
Overall Recruitment Status
Completed
Study Start Date
October 2002 (undefined)
Primary Completion Date
December 2009 (Actual)
Study Completion Date
December 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Irvine

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
PURPOSE Obesity is a growing problem in the United States. Severe obesity, known as "morbid obesity", is defined as being 100 pounds in excess of ideal body weight. Nonsurgical treatments for morbid obesity include exercise, dietary restriction, behavior modification, and pharmacological intervention. However, it is estimated that most patients undergoing nonsurgical treatments for weight reduction will regain their weight within 2 to 4 years after treatment. According to the NIH consensus conference in 1991, surgery remains the only effective sustained weight loss treatment for morbid obesity. The Roux-en-Y gastric bypass (GBP) is currently considered the gold standard bariatric surgical operation. Mean weight loss following GBP is approximately 65% of the excess body weight during the first 12 to 18 months postoperatively. Long-term weight loss is in the range of 55-70% of excess body weight loss. Recently, the laparoscopic approach to GBP was reported. Wittgrove and colleagues reported their results of 75 patients who underwent laparoscopic GBP and demonstrated significant short-term advantages with comparable weight loss and reversal of comorbidities compared to the open approach. However, GBP might it be done laparoscopic or open approach can potentially be associated with significant morbidity and mortality such as anastomotic leak, pulmonary embolism, bowel obstruction, and postoperative stricture. The FDA recently approved the laparoscopic adjustable banding system (LAP-BAND) for use in the United States in June 2001. The LAP-BAND system is a device designed to induce weight loss in severely obese patients. It is surgically placed around the proximal stomach to create a small proximal stomach pouch and restricted opening, or stoma, through which passage of food will be slowed. An inflatable portion along the inner aspect of the band is connected to an access port, placed intramuscularly. This enabled stoma adjustments to be made without the need for further surgery. The advantages of the LAP-BAND system included no cutting or opening of the stomach wall, ability to adjust the stoma and a technically easier operation to perform than laparoscopic GBP. We wanted to evaluate if the LAP-BAND procedure is as effective as the laparoscopic GBP procedure for treatment of morbid obesity.
Detailed Description
RATIONALE: Morbid obesity and its health consequences is increasing in the United States Roux-en-Y GBP is an effective treatment for morbid obesity but can be associated with substantial morbidities LAP-BAND system can be an effective treatment for morbidly obese patients with potentially reduced morbidity compared to laparoscopic GBP HYPOTHESIS: LAP-BAND can be performed safely and are associated with reduced postoperative pain, decrease in morbidity, decrease ICU and hospital stay, reduced costs, comparable improvement in quality-of-life, and acceptable long-term weight loss compared with laparoscopic GBP LAP-BAND is associated with a decrease in fluid requirement in the perioperative period, improved postoperative pulmonary function, and lower intraabdominal pressure compared to laparoscopic GBP LAP-BAND does not alter esophageal motility and is effective in improvement of gastroesophageal reflux disease (GERD) symptoms. OBJECTIVES AND SPECIFIC AIMS: To determine the short-term outcome, quality-of-life, costs, and long-term weight loss after laparoscopic GBP compared with LAP-BAND. To compare physiologic changes such as perioperative fluid requirement, postoperative pulmonary function, and intraabdominal pressure after laparoscopic GBP and LAP-BAND. To evaluate the effect of LAP-BAND on esophageal motility and its effectiveness in controlling gastroesophageal reflux symptoms (GERD) for morbidly obese patients with GERD. Please note: All physician, hospital, laboratory costs, the barium study tests, and the performance of the operation will be billed to the subject or their insurer as customary since these procedures are standard of care regardless of participation in the study. The research procedures such as the pulmonary function tests, intra-abdominal pressure, body fat composition tests, resting energy expenditure, exercise testing, strength testing, nutritional assessments, and esophageal function tests are considered research-related and will be paid for by the investigator.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Morbid Obesity
Keywords
Morbid Obesity, Laparoscopic Gastric Bypass, Laparoscopic Gastric Banding

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
197 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Laparoscopic Gastric Bypass
Arm Type
Active Comparator
Arm Description
Subject undergoes Laparoscopic Gastric Bypass
Arm Title
LAP-BAND
Arm Type
Active Comparator
Arm Description
Subject undergoes LAP-BAND procedure
Intervention Type
Procedure
Intervention Name(s)
Gastric bypass surgery
Other Intervention Name(s)
gastric bypass, bypass surgery, weight loss surgery
Intervention Description
in order to meet health requirements for patient, gastric bypass surgery was undergone
Intervention Type
Procedure
Intervention Name(s)
Lap-Band
Other Intervention Name(s)
weight loss surgery, band
Intervention Description
in order to meet health requirements for patient, gastric band surgery was undergone
Primary Outcome Measure Information:
Title
Excess Weight Loss From Pre-operation to 5 Years Post-operation
Description
weight loss as measured by change in percent of excess body weight
Time Frame
Baseline to 5 years
Secondary Outcome Measure Information:
Title
Changes in Quality of Life- Physical Functioning Using SF-36 Questionnaire Pre-operation to 12 Months Post-operation
Description
change in quality of life survey response where 0 is non-functioning and 100 is fully functioning
Time Frame
Baseline to 12 months
Title
Cost of Procedure to the Medical Facility on Date of Procedure
Description
operative and post-operative direct costs including hospital service costs per patient. costs reflect the average cost per patient in each of the two groups (band vs. bypass) at a single time point: date of surgery.
Time Frame
date of surgery
Title
Changes in Quality of Life- Role- Physical Using SF-36 Questionnaire Pre-operation to 12 Months Post-operation
Description
change in quality of life survey response for physical aspects of life using the SF-36 questionnaire where 0 corresponds to no Role-Physical and 100 corresponds to full Role-Physical
Time Frame
Baseline to 12 months
Title
Changes in Quality of Life- Bodily Pain Using SF-36 Questionnaire Pre-operation to 12 Months Post-operation
Description
change in quality of life survey response for bodily pain using the SF-36 questionnaire where 0 corresponds to no bodily pain and 100 corresponds to complete bodily pain
Time Frame
Baseline to 12 months
Title
Changes in Quality of Life: General Health Using SF-36 Questionnaire Pre-operation to 12 Months Post-operation
Description
change in quality of life survey response for general health using the SF-36 questionnaire where 0 corresponds to no general health satisfaction and 100 corresponds to complete health satisfaction
Time Frame
Baseline to 12 months
Title
Changes in Quality of Life- Vitality Using SF-36 Questionnaire Pre-operation to 12 Months Post-operation
Description
change in quality of life survey response for vitality as measured using the SF-36 questionnaire with worst score being 0 and best score being 100 on a 1-100 point scale.
Time Frame
Baseline to 12 months
Title
Changes in Quality of Life- Social Functioning Using SF-36 Questionnaire Pre-operation to 12 Months Post-operation
Description
change in quality of life survey response for social functioning as measured using the SF-36 questionnaire where 0 corresponds to no social functioning and 100 corresponds to full social functioning
Time Frame
Baseline to 12 months
Title
Changes in Quality of Life- Role- Emotional Using SF-36 Questionnaire Pre-operation to 12 Months Post-operation
Description
change in quality of life survey response for the emotional role using the SF-36 questionnaire where 0 corresponds to no emotional role and 100 corresponds to full emotional role
Time Frame
Baseline to 12 months
Title
Changes in Quality of Life- Mental Health Using SF-36 Questionnaire From Pre-operation to 12 Months Post-operation
Description
change in quality of life survey response for mental health using the SF-36 questionnaire where 0 corresponds to no mental health well-being and 100 corresponds to complete mental health well-being
Time Frame
Baseline to 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Eligibility: Inclusion Criteria: Male or female patients with BMI of 40-60 kg/m2 or 35 kg/m2 with comorbidities Good health status with acceptable operative risk (good cardiopulmonary function) Willingness to follow protocol requirements: Signing informed consent, follow-up, and completing protocol diagnostic tests Exclusion Criteria: Prior upper abdominal surgery except cholecystectomy Large abdominal ventral hernia Patients with hiatal hernia Inadequate prior medical management Lack of patient's motivation and contribution to long-term success Unacceptable operative risk Minors and pregnant women are excluded as these patients do not qualify for the bariatric procedures. Minors are not psychologically fit to undergo such surgery and pregnant women are excluded because of safety for the fetus.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Ninh T Nguyen, MD
Organizational Affiliation
University of California, Irvine Medical Center, Orange, CA
Official's Role
Principal Investigator
Facility Information:
Facility Name
Univeristy of California, Irvine, Medical Center
City
Orange
State/Province
California
ZIP/Postal Code
92868
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
19730234
Citation
Nguyen NT, Slone JA, Nguyen XM, Hartman JS, Hoyt DB. A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg. 2009 Oct;250(4):631-41. doi: 10.1097/SLA.0b013e3181b92480.
Results Reference
result
Links:
URL
http://www.ncbi.nlm.nih.gov/pubmed/19730234?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&ordinalpos=2
Description
PubMed Abstract

Learn more about this trial

Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity

We'll reach out to this number within 24 hrs